These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31922028)

  • 1. Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus.
    Chamarthi B; Vinik A; Ezrokhi M; Cincotta AH
    Endocrinol Diabetes Metab; 2020 Jan; 3(1):e00101. PubMed ID: 31922028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.
    Gaziano JM; Cincotta AH; Vinik A; Blonde L; Bohannon N; Scranton R
    J Am Heart Assoc; 2012 Oct; 1(5):e002279. PubMed ID: 23316290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
    Chamarthi B; Cincotta AH
    Postgrad Med; 2017 May; 129(4):446-455. PubMed ID: 28374645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.
    Chamarthi B; Ezrokhi M; Rutty D; Cincotta AH
    Postgrad Med; 2016 Nov; 128(8):761-769. PubMed ID: 27687032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
    Cincotta AH; Cersosimo E; Alatrach M; Ezrokhi M; Agyin C; Adams J; Chilton R; Triplitt C; Chamarthi B; Cominos N; DeFronzo RA
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus.
    Chamarthi B; Gaziano JM; Blonde L; Vinik A; Scranton RE; Ezrokhi M; Rutty D; Cincotta AH
    J Diabetes Res; 2015; 2015():157698. PubMed ID: 26060823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.
    Ezrokhi M; Zhang Y; Luo S; Cincotta AH
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary.
    Raskin P; Cincotta AH
    Expert Rev Endocrinol Metab; 2016 Mar; 11(2):113-148. PubMed ID: 30058874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents.
    Vinik AI; Cincotta AH; Scranton RE; Bohannon N; Ezrokhi M; Gaziano JM
    Endocr Pract; 2012; 18(6):931-43. PubMed ID: 23186965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
    Cincotta AH
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes.
    Gaziano JM; Cincotta AH; O'Connor CM; Ezrokhi M; Rutty D; Ma ZJ; Scranton RE
    Diabetes Care; 2010 Jul; 33(7):1503-8. PubMed ID: 20332352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quick-release bromocriptine for treatment of type 2 diabetes.
    Mikhail N
    Curr Drug Deliv; 2011 Sep; 8(5):511-6. PubMed ID: 21696353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine: old drug, new formulation and new indication.
    Holt RI; Barnett AH; Bailey CJ
    Diabetes Obes Metab; 2010 Dec; 12(12):1048-57. PubMed ID: 20977575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study.
    Roe ED; Chamarthi B; Raskin P
    J Diabetes Res; 2015; 2015():834903. PubMed ID: 26060825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
    Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Diamant M; van Raalte DH
    Eur J Endocrinol; 2017 Jan; 176(1):77-86. PubMed ID: 27777261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Bromocriptine-QR in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Liang W; Gao L; Li N; Wang B; Wang L; Wang Y; Yang H; You L; Hou J; Chen S; Zhu H; Jiang Y; Pan H
    Horm Metab Res; 2015 Oct; 47(11):805-12. PubMed ID: 26332757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats.
    Tadepalli AS; Novak PJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):93-105. PubMed ID: 6141774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus.
    Schwartz SS; Zangeneh F
    Postgrad Med; 2016 Nov; 128(8):828-838. PubMed ID: 27458683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of resting heart rate on new-onset diabetes in population without hypertension].
    Wu SL; Liu XX; Zhu CR; Wei XM; Li HY; DU X; Lin LM; Li JJ; Liu Y; Cai J; Shi JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):968-73. PubMed ID: 24370229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine in type 2 diabetes mellitus.
    Shivaprasad C; Kalra S
    Indian J Endocrinol Metab; 2011 Jul; 15(Suppl 1):S17-24. PubMed ID: 21847449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.